Join
Live feed
·
INSIDERFilingvia Quantisnow
Neos Therapeutics, Inc. logo

SEC Form 4: I Richard Eisenstadt disposed of $13,740 worth of Common Stock (16,215 units at $0.85), decreasing direct ownership by 11% to 126,245 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NEOS (Neos Therapeutics, Inc.) and more on Quantisnow.